Ronald Kirk Huntsman - Net Worth and Insider Trading

Ronald Kirk Huntsman Net Worth

The estimated net worth of Ronald Kirk Huntsman is at least $158,542 dollars as of 2024-06-05. Ronald Kirk Huntsman is the CEO of Vivos Therapeutics Inc and owns about 73,061 shares of Vivos Therapeutics Inc (VVOS) stock worth over $158,542. Details can be seen in Ronald Kirk Huntsman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ronald Kirk Huntsman has not made any transactions after 2023-06-20 and currently still holds the listed stock(s).

Transaction Summary of Ronald Kirk Huntsman

To

Ronald Kirk Huntsman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ronald Kirk Huntsman owns 1 companies in total, including Vivos Therapeutics Inc (VVOS) .

Click here to see the complete history of Ronald Kirk Huntsman’s form 4 insider trades.

Insider Ownership Summary of Ronald Kirk Huntsman

Ticker Comapny Transaction Date Type of Owner
VVOS Vivos Therapeutics Inc 2023-06-20 director & 10 percent owner & Chairman & CEO

Ronald Kirk Huntsman Latest Holdings Summary

Ronald Kirk Huntsman currently owns a total of 1 stock. Ronald Kirk Huntsman owns 73,061 shares of Vivos Therapeutics Inc (VVOS) as of June 20, 2023, with a value of $158,542.

Latest Holdings of Ronald Kirk Huntsman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VVOS Vivos Therapeutics Inc 2023-06-20 73,061 2.17 158,542

Holding Weightings of Ronald Kirk Huntsman


Ronald Kirk Huntsman Form 4 Trading Tracker

According to the SEC Form 4 filings, Ronald Kirk Huntsman has made a total of 10 transactions in Vivos Therapeutics Inc (VVOS) over the past 5 years, including 10 buys and 0 sells. The most-recent trade in Vivos Therapeutics Inc is the acquisition of 560 shares on June 20, 2023, which cost Ronald Kirk Huntsman around $7,420.

Insider Trading History of Ronald Kirk Huntsman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ronald Kirk Huntsman Trading Performance

GuruFocus tracks the stock performance after each of Ronald Kirk Huntsman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ronald Kirk Huntsman is -28.73%. GuruFocus also compares Ronald Kirk Huntsman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ronald Kirk Huntsman within 3 months outperforms 0 times out of 10 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ronald Kirk Huntsman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ronald Kirk Huntsman

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 8 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.66 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 0.61 LIMIT LIMIT LIMIT LIMIT LIMIT

Ronald Kirk Huntsman Ownership Network

Ownership Network List of Ronald Kirk Huntsman

No Data

Ownership Network Relation of Ronald Kirk Huntsman

Insider Network Chart

Ronald Kirk Huntsman Owned Company Details

What does Vivos Therapeutics Inc do?

Who are the key executives at Vivos Therapeutics Inc?

Ronald Kirk Huntsman is the director & 10 percent owner & Chairman & CEO of Vivos Therapeutics Inc. Other key executives at Vivos Therapeutics Inc include Chief Financial Officer Bradford K. Amman , and director & 10 percent owner & Chief Medical Officer Gurdev Dave Singh .

Vivos Therapeutics Inc (VVOS) Insider Trades Summary

Over the past 18 months, Ronald Kirk Huntsman made 4 insider transaction in Vivos Therapeutics Inc (VVOS) with a net purchase of 59,021.

In summary, during the past 3 months, insiders sold 0 shares of Vivos Therapeutics Inc (VVOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vivos Therapeutics Inc (VVOS) were sold and 2,361 shares were bought by its insiders, resulting in a net purchase of 2,361 shares.

Vivos Therapeutics Inc (VVOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vivos Therapeutics Inc Insider Transactions

No Available Data

Ronald Kirk Huntsman Mailing Address

Above is the net worth, insider trading, and ownership report for Ronald Kirk Huntsman. You might contact Ronald Kirk Huntsman via mailing address: 9137 Ridgeline Boulevard, Suite 135, Highlands Ranch Co 80129.

Discussions on Ronald Kirk Huntsman

No discussions yet.